Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of tumor ALK status in neuroblastoma patients using peripheral blood.

Cancer medicine - 1 Apr 2015

Combaret Valérie, Iacono Isabelle, Bellini Angela, Bréjon Stéphanie, Bernard Virginie, Marabelle Aurélien, Coze Carole, Pierron Gaelle, Lapouble Eve, Schleiermacher Gudrun, Blay Jean Yves

Abstract excerpt

New protocols based on ALK-targeted therapy by crizotinib or other ALK-targeting molecules have opened for the treatment of patients with neuroblastoma (NB) if their tumors showed mutation and/or amplification of the ALK gene. However, tumor samples are not always available for analysis of ALK mu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Child
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Neuroblastoma

Share to Polymerase Chain Reaction

Share to Receptor Protein-Tyrosine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 25653133
DOI: 10.1002/cam4.414
PMCID: PMC4402069

Genes

ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25653133-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of tumor ALK status in neuroblastoma patients using peripheral blood.PMID 25653133Read ↗

Using droplet digital PCR to analyzeMYCNandALKcopy number in plasma from patients with neuroblastomaSemantic proximity Read ↗

Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA.Semantic proximity Read ↗

Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction.Semantic proximity Read ↗

Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and ALK Genotyping via Cell-Free Circulating Tumor DNA ProfilingSemantic proximity Read ↗

Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular ToolSemantic proximity Read ↗

Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.Semantic proximity Read ↗

Current and Emerging Applications of Droplet Digital PCR in Oncology.Semantic proximity Read ↗

Double Drop-Off Droplet Digital PCR: A Novel, Versatile Tool for Mutation Screening and Residual Disease Monitoring in Acute Myeloid Leukemia Using Cellular or Cell-Free DNA.Semantic proximity Read ↗

Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma.Semantic proximity Read ↗

Multiplexed Droplet Digital PCR Assays for the Simultaneous Screening of Major Genetic Alterations in Tumors of the Central Nervous SystemSemantic proximity Read ↗

JAK2 V617F mutation can be reliably detected in serum using droplet digital PCR.Semantic proximity Read ↗

Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.